Follow
Venkata D Yellapantula
Venkata D Yellapantula
Assistant Professor, Childrens Hospital Los Angeles
Verified email at genome.wustl.edu
Title
Cited by
Cited by
Year
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
21052018
Age-related mutations associated with clonal hematopoietic expansion and malignancies
M Xie, C Lu, J Wang, MD McLellan, KJ Johnson, MC Wendl, ...
Nature medicine 20 (12), 1472-1478, 2014
18782014
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1671*2020
Proteogenomics connects somatic mutations to signalling in breast cancer
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
15262016
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
7752017
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
G Ledergor, A Weiner, M Zada, SY Wang, YC Cohen, ME Gatt, N Snir, ...
Nature medicine 24 (12), 1867-1876, 2018
2132018
Timing the initiation of multiple myeloma
EH Rustad, V Yellapantula, D Leongamornlert, N Bolli, G Ledergor, ...
Nature communications 11 (1), 1917, 2020
1302020
Systematic discovery of complex insertions and deletions in human cancers
K Ye, J Wang, R Jayasinghe, EW Lameijer, JF McMichael, J Ning, ...
Nature medicine 22 (1), 97-104, 2016
1172016
Revealing the impact of structural variants in multiple myeloma
EH Rustad, VD Yellapantula, D Glodzik, KH Maclachlan, B Diamond, ...
Blood cancer discovery 1 (3), 258-273, 2020
892020
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
B Oben, G Froyen, KH Maclachlan, D Leongamornlert, F Abascal, ...
Nature communications 12 (1), 1861, 2021
742021
Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma: the …
O Landgren, M Hultcrantz, B Diamond, AM Lesokhin, S Mailankody, ...
JAMA oncology 7 (6), 862-868, 2021
652021
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
V Yellapantula, M Hultcrantz, EH Rustad, E Wasserman, D Londono, ...
Blood cancer journal 9 (12), 101, 2019
502019
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
D Kazandjian, E Hill, M Hultcrantz, EH Rustad, V Yellapantula, T Akhlaghi, ...
Blood Cancer Journal 9 (2), 15, 2019
442019
Accelerated single cell seeding in relapsed multiple myeloma
Nature Communiations 3617 (https://doi.org/10.1038/s41467-020-17459), 2020
43*2020
Group MCW
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cancer Genome Atlas Research N, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart …, 2018
432018
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
F Maura, EH Rustad, V Yellapantula, M Łuksza, D Hoyos, KH Maclachlan, ...
Leukemia 34 (5), 1476-1480, 2020
422020
Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy provides unprecedented MRD negativity rates in newly diagnosed multiple myeloma: a …
O Landgren, M Hultcrantz, AM Lesokhin, S Mailankody, H Hassoun, ...
Blood 134, 862, 2019
412019
Interim analysis of the mmrf commpass trial, a longitudinal study in multiple myeloma relating clinical outcomes to genomic and immunophenotypic profiles
JJ Keats, DW Craig, W Liang, Y Venkata, A Kurdoglu, J Aldrich, D Auclair, ...
Blood, The Journal of the American Society of Hematology 122 (21), 532-532, 2013
392013
Germline determinants of the somatic mutation landscape in 2,642 cancer genomes
SM Waszak, G Tiao, B Zhu, T Rausch, F Muyas, B Rodriguez-Martin, ...
BioRxiv, 208330, 2017
342017
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
KH Maclachlan, EH Rustad, A Derkach, B Zheng-Lin, V Yellapantula, ...
Nature communications 12 (1), 5172, 2021
322021
The system can't perform the operation now. Try again later.
Articles 1–20